Growth Hormone Research Peptides
Tesamorelin
Tesamorelin, is a syntheitic peptide consiting of 44 amino acids. It is a growth-hormone-releasing hormone (GHRH) analogue researched for the treatment of HIV-associated lipodystrophy (dysfunctional, toxic fat deposition). It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment, and the reduction visceral fat. This peptide has been found to reduce adiposity by nearly 20% in this population [1]. Research suggests that tesamorelin is approximately 4 times more effective in reducing adiposity than all of the other available therapies combined [2].
Overview
Full product description will be added soon.
Technical Specifications
- Molecular Formula
- Molecular Weight
- 5195.91 g/mol
- Purity
- 99% HPLC
- Length
- 44 aa
- CAS Number
- 9017-08-9
- Research Area
- —
Molecular Information
- Molecular Formula
- Molecular Weight
- 5195.91 g/mol
- CAS Number
- 9017-08-9
- Sequence Length
- 44 aa
Storage Information
- Storage
- Store lyophilized at -20°C; protect from light and moisture. Reconstitute with bacteriostatic water; store reconstituted material refrigerated and use per laboratory procedure.
- Appearance
- Lyophilized powder
- Solubility
- Soluble in bacteriostatic water; please refer to the product COA for specific solvent recommendations.
Documentation
Documentation is available on request. Request COA / specification sheet
Need This Peptide in Larger Quantities?
Request bulk specifications, custom purity requirements, and documentation for research programs.